HOUSE-BILL 4055: H.R.4055 - Dialysis-Related Amyloidosis Treatment Act of 2025

Overall Constitutional Implications

The bill represents a significant step toward improving health care access for individuals suffering from dialysis-related amyloidosis, particularly benefiting vulnerable populations. By expanding Medicare coverage, it aligns with constitutional principles aimed at promoting public welfare and health equity.

Key Individual Rights Affected

• Right to Health Care
• Equal Protection under the Law

Constitutional Provisions

• 14th Amendment - Equal Protection Clause
• Commerce Clause
• General Welfare Clause

Potential Constitutional Challenges Or Support

While the bill is likely to be viewed positively in terms of public health, challenges may arise regarding its implementation and whether it adequately addresses the needs of marginalized groups. If certain populations continue to face barriers to accessing these treatments, it could raise equal protection concerns.

Summary

HOUSE-BILL 4055 expands access to necessary medical treatments for individuals with dialysis-related amyloidosis, which is a positive development in promoting health equity. However, careful attention must be paid to ensure that all demographic groups, particularly those facing systemic barriers, can benefit from this expanded coverage. The bill's alignment with constitutional principles of equal protection and public welfare underscores its importance in addressing health disparities.